SFU researchers have created a patent-pending, optical diagnostic probe capable of more safely and non-invasively detect early stage breast cancer. Recent testing of their diffuse optical breast-scanning (DOB-Scan) probe during an initial clinical study at Surrey’s Jim Pattison Outpatient Care and Surgery Centre found that it can conclusively confirm cancer, while also providing more detail about “suspicious tissue” than conventional…
Read More
By the time a person with Parkinson’s disease (PD) receives a diagnosis, they have already lost a substantial amount of their brain dopamine and a lesser extent of brain serotonin. A new international study looked at people with an inherited gene mutation linked to PD prior to or at the earliest stages of disease onset to determine if a reduction…
Read More
B.C. billionaire Jim Pattison has donated $75 million to the St. Paul’s Hospital Foundation in Vancouver. The St. Paul’s Foundation says the donation is the largest by a private citizen to a single medical facility in Canadian history. “Jim Pattison’s gift will help us realize an exceptionally rare opportunity to build a major medical and research centre from the ground up,”…
Read More
STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells STEMCELL Technologies announces the development of CloneR™, a novel medium formulation to aid researchers in their ability to successfully genome edit human pluripotent stem cells. This supplement represents a dramatic improvement over existing technologies. Editing the pluripotent stem cell genome relies heavily on the survival of…
Read More
Autism Spectrum Disorders (ASDs) are defined by significant challenges with communication, social reciprocity, and structured behaviour. ASDs are currently the most common childhood developmental disabilities with 1 in 68 individuals currently diagnosed with ASD. The lifetime cost for educational, health-care, and social services averages $5-8 million per person, and British Columbia alone contributes hundreds of millions of dollars to treatment…
Read More
UBC scientists have scanned the genome of cannabis plants to find the genes responsible for giving various strains their lemony, skunky or earthy flavours, an important step for the budding legal cannabis industry. “The goal is to develop well-defined and highly-reproducible cannabis varieties. This is similar to the wine industry, which depends on defined varieties such as chardonnay or merlot…
Read More
Imagine if before taking a medication, you could walk into your local pharmacy and take a test that could accurately predict whether the medication would work for you and the dosage best suited to you—all based on your DNA. This is the genesis behind a BC-based research project “Genomics for Precision Drug Therapy in the Community Pharmacy”, the first of…
Read More
Almost half the cells and just one per cent of the unique genes found in our bodies are human: the rest are from bacteria, archaea, fungi, and viruses. Together, they weigh roughly three pounds, about the same amount as the human brain. Most of those microbes are in our gastro-intestinal tract, with the highest microbial density and activity found in…
Read More